Background Background Depressive symptoms
Depressive symptoms are associated with cognitive decline in are associated with cognitive decline in elderly people, butthe nature of their elderly people, butthe nature of their temporal relationship remains equivocal. temporal relationship remains equivocal.
Aims Aims To test whether depressive
To test whether depressive symptoms predict cognitive decline in symptoms predict cognitive decline in elderly people with normal cognition. elderly people with normal cognition.
Method Method The Center for Epidemiologic
The Center for Epidemiologic Study depression scale (CES^D) and the Study depression scale (CES^D) and the Mini-Mental State Examination (MMSE) Mini-Mental State Examination (MMSE) were used to evaluate depressive were used to evaluate depressive symptomatology and cognitive symptomatology and cognitive functioning, respectively. A sample of1003 functioning, respectively. A sample of1003 persons aged 59^71years and with a persons aged 59^71years and with a MMSE score of 26 or over was selected. MMSE score of 26 or over was selected. Cognitive decline was defined as a drop of Cognitive decline was defined as a drop of at least 3 points on the MMSE at 4-year at least 3 points on the MMSE at 4-year follow-up. follow-up.
Results
Results Baseline high levels of Baseline high levels of depressive symptoms predicted a higher depressive symptoms predicted a higher risk of cognitive decline at 4-year followrisk of cognitive decline at 4-year followup.The MMSE score of participants with up.The MMSE score of participants with depression was more likely to fall below 26 depression was more likely to fall below 26 at 2-year follow-up and to remain below at at 2-year follow-up and to remain below at 4-year follow-up than the MMSE score of 4-year follow-up than the MMSE score of those without depressive symptoms. those without depressive symptoms. Persistent but not episodic depressive Persistent but not episodic depressive episodes were associated with cognitive episodes were associated with cognitive decline. decline.
Conclusions Conclusions High levels of depressive
High levels of depressive symptoms, when persistent, are symptoms, when persistent, are associated with cognitive decline in a associated with cognitive decline in a sample of elderly people. sample of elderly people.
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Many studies have shown an association Many studies have shown an association between depressive symptoms and demenbetween depressive symptoms and dementia or cognitive decline (Jorm, 2000) but tia or cognitive decline (Jorm, 2000) but the nature of this relationship remains equithe nature of this relationship remains equivocal. Depressive symptoms have been vocal. Depressive symptoms have been found to precede cognitive decline (Yaffe found to precede cognitive decline (Yaffe et al et al, 1999) or to follow the onset of , 1999) or to follow the onset of dementia (Chen dementia (Chen et al et al, 1999) . Some studies , 1999). Some studies did not report any significant association did not report any significant association (Dufouil (Dufouil et al et al, 1996; Palsson , 1996; Palsson et al et al, 1999) . , 1999). Bassuk Bassuk et al et al (1998) found that depression (1998) found that depression predicted cognitive decline over 3-year predicted cognitive decline over 3-year and 6-year follow-up periods for people and 6-year follow-up periods for people with medium, but not high, cognitive scores with medium, but not high, cognitive scores at baseline. Geerlings at baseline. Geerlings et al et al (2000) found (2000) found that depression was associated with an that depression was associated with an increased risk of Alzheimer's disease and increased risk of Alzheimer's disease and cognitive decline only in people with higher cognitive decline only in people with higher levels of education. The objectives of our levels of education. The objectives of our study were: study were:
(a) (a) to test whether depressive symptoms to test whether depressive symptoms predict cognitive decline in an elderly predict cognitive decline in an elderly population with normal cognition; population with normal cognition; (b) (b) to evaluate whether depression predicts to evaluate whether depression predicts persistent low cognitive functioning at persistent low cognitive functioning at follow-up; follow-up; (c) (c) to examine whether people reporting to examine whether people reporting episodic or persistent depressive episodic or persistent depressive episodes show a similar or different episodes show a similar or different association with cognitive decline. association with cognitive decline.
METHOD METHOD
Sample and study design Sample and study design Interviews and examinations were conInterviews and examinations were conducted at the study centre. Data on demoducted at the study centre. Data on demographic background, occupation, medical graphic background, occupation, medical history, drug use and personal habits were history, drug use and personal habits were obtained using a standardised questionobtained using a standardised questionnaire during a face-to-face interview. Mean naire during a face-to-face interview. Mean weekly alcohol intake was estimated from a weekly alcohol intake was estimated from a detailed description of alcoholic beverage detailed description of alcoholic beverage consumption during a typical week. Particiconsumption during a typical week. Participants were asked whether they had suffered pants were asked whether they had suffered from any of six specified common diseases from any of six specified common diseases (myocardial infarction, angina, stroke, (myocardial infarction, angina, stroke, hypercholesterolaemia, hypertension, diahypercholesterolaemia, hypertension, diabetes) or had any other chronic medical betes) or had any other chronic medical condition. All drugs used during the month condition. All drugs used during the month preceding the examination were noted, and preceding the examination were noted, and were subsequently coded according to the were subsequently coded according to the classification proposed by the French classification proposed by the French national prescription handbook, the national prescription handbook, the Guide Guide National de Prescription des Medicaments National de Prescription des Me´dicaments (1991). Psychotropic drugs included (1991) . Psychotropic drugs included anxiolytic, hypnotic, sedative, neuroleptic, anxiolytic, hypnotic, sedative, neuroleptic, antidepressant and normothymic agents. antidepressant and normothymic agents.
The group was invited to participate in The group was invited to participate in two follow-up examinations, which were two follow-up examinations, which were conducted 2 years and 4 years after the conducted 2 years and 4 years after the baseline evaluation. baseline evaluation.
Population Population
Among the initial sample of 1389 persons, Among the initial sample of 1389 persons, 200 (14.4%) had a baseline score on the 200 (14.4%) had a baseline score on the Mini-Mental State Examination (MMSE) Mini-Mental State Examination (MMSE) below 26 and were excluded from the below 26 and were excluded from the analysis. Of the 1189 persons considered analysis. Of the 1189 persons considered eligible for the study, 18 died before the eligible for the study, 18 died before the 4-year follow-up assessment, 137 were not 4-year follow-up assessment, 137 were not followed up at 2 years or 4 years, and followed up at 2 years or 4 years, and 31 had not completed the Center for 31 had not completed the Center for Epidemiologic Studies depression scale Epidemiologic Studies depression scale (CES-D) (CES-D) rating at baseline. So, 84% of rating at baseline. So, 84% of eligible participants were analysed eligible participants were analysed ( (n n¼1003). A further 31 participants had 1003). A further 31 participants had no CES-D assessment at 2-year or 4-year no CES-D assessment at 2-year or 4-year follow-up. follow-up.
Cognitive function testing Cognitive function testing
A trained psychologist administered a A trained psychologist administered a battery of tests assessing different areas of battery of tests assessing different areas of cognitive and psychomotor functioning. cognitive and psychomotor functioning. Tests were chosen with special regard for Tests were chosen with special regard for their sensitivity to ageing. For the current their sensitivity to ageing. For the current analysis we considered a measure of global analysis we considered a measure of global cognitive abilities, the MMSE (Folstein cognitive abilities, the MMSE (Folstein et et al al, 1975) , which yields scores ranging from , 1975), which yields scores ranging from 0 to 30. The MMSE was administered to 0 to 30. The MMSE was administered to participants at baseline and at 2-year and participants at baseline and at 2-year and 4-year follow-up. 4-year follow-up. The CES-D was sent to the participants The CES-D was sent to the participants by mail approximately 3 weeks before the by mail approximately 3 weeks before the examination and completed questionnaires examination and completed questionnaires were brought back at the time of the were brought back at the time of the examination. The instrument was adminisexamination. The instrument was administered to the participants at the baseline tered to the participants at the baseline assessment and at 2-year and 4-year assessment and at 2-year and 4-year follow-up. follow-up.
Data analysis Data analysis
We excluded from the data analysis people We excluded from the data analysis people with a baseline MMSE score lower than 26 with a baseline MMSE score lower than 26 for two reasons: to exclude those with subfor two reasons: to exclude those with subthreshold levels of dementia, and to include threshold levels of dementia, and to include only those at risk of cognitive decline. only those at risk of cognitive decline.
The differences in MMSE scores The differences in MMSE scores between baseline and 4-year follow-up between baseline and 4-year follow-up examinations were analysed as quantitative examinations were analysed as quantitative variables, and also as binary variables. For variables, and also as binary variables. For the latter analyses, cognitive decline was the latter analyses, cognitive decline was defined as a decrease of 3 points or more defined as a decrease of 3 points or more in the MMSE scores. We defined 'low cogin the MMSE scores. We defined 'low cognitive functioning at follow-up' as MMSE nitive functioning at follow-up' as MMSE scores of 25 or less at 2-year and 4-year scores of 25 or less at 2-year and 4-year follow-up. Participants were defined as follow-up. Participants were defined as having high baseline levels of depressive having high baseline levels of depressive symptoms when their baseline CES-D score symptoms when their baseline CES-D score was above the gender-specific cut-off point. was above the gender-specific cut-off point. In order to evaluate whether the risk of cogIn order to evaluate whether the risk of cognitive decline is higher when the participant nitive decline is higher when the participant reports several depressive episodes at reports several depressive episodes at follow-up evaluation, we defined three follow-up evaluation, we defined three study groups. Participants reporting high study groups. Participants reporting high levels of depressive symptoms at one or at levels of depressive symptoms at one or at more than one evaluation were assigned more than one evaluation were assigned to an 'episodic' or a 'persistent' depressive to an 'episodic' or a 'persistent' depressive group, respectively, and were compared group, respectively, and were compared with participants who did not have high with participants who did not have high depressive symptom scores at any of the depressive symptom scores at any of the three assessments. three assessments.
We tested whether a high depressive We tested whether a high depressive symptom score was associated with cogsymptom score was associated with cognitive decline using multivariate analyses nitive decline using multivariate analyses (covariance analysis and logistic regression (covariance analysis and logistic regression models). All multivariate analyses were models). All multivariate analyses were adjusted for gender, age, education (years adjusted for gender, age, education (years of schooling), alcohol (mean weekly alcoof schooling), alcohol (mean weekly alcohol intake evaluated in millilitres of pure hol intake evaluated in millilitres of pure alcohol) and tobacco use (current smokers, alcohol) and tobacco use (current smokers, former smokers, or never smokers), psychoformer smokers, or never smokers), psychotropic drug use and the presence of tropic drug use and the presence of chronic medical diseases, because these chronic medical diseases, because these variables are known to be significantly variables are known to be significantly associated with cognitive performance and associated with cognitive performance and psychopathological characteristics. psychopathological characteristics.
In order to examine whether the In order to examine whether the observed relationship between CES-D observed relationship between CES-D score and cognitive decline was due to score and cognitive decline was due to depressed mood rather than to the cumuladepressed mood rather than to the cumulative number of symptoms, we evaluated tive number of symptoms, we evaluated whether the CES-D sub-score 'depressive whether the CES-D sub-score 'depressive affect' was predictive of cognitive decline, affect' was predictive of cognitive decline, using linear and logistic regression models. using linear and logistic regression models. We calculated the 'depressive affect' subWe calculated the 'depressive affect' subscore, by summing the scores of items score, by summing the scores of items measuring the cognitive symptoms of measuring the cognitive symptoms of depression ('bothered', 'blues', 'depressed', depression ('bothered', 'blues', 'depressed', 'fearful', 'lonely', 'cried' and 'sad') (Radloff 'fearful', 'lonely', 'cried' and 'sad') (Radloff & Teri, 1986) . The sub-score ranged from & Teri, 1986). The sub-score ranged from 0 to 21. 0 to 21.
Statistical testing was done at the Statistical testing was done at the conventional two-tailed conventional two-tailed a a-level of 0.05.
-level of 0.05.
Data were analysed using the SAS package, Data were analysed using the SAS package, Version 6 (SAS Institute, 1989). Version 6 (SAS Institute, 1989).
RESULTS RESULTS

Population characteristics Population characteristics
The population characteristics are shown in The population characteristics are shown in Table 1 . Participants with high levels of Table 1 . Participants with high levels of depressive symptoms more often used depressive symptoms more often used tobacco and psychotropic drugs. tobacco and psychotropic drugs.
Comparison between participants
Comparison between participants according to follow-up according to follow-up
A slightly higher percentage of participants A slightly higher percentage of participants who were not followed up had a high who were not followed up had a high depressive symptom score at baseline; they depressive symptom score at baseline; they also had lower MMSE scores than those also had lower MMSE scores than those followed up. Participants not followed up followed up. Participants not followed up had fewer years of schooling and used more had fewer years of schooling and used more psychotropic drugs. No difference was psychotropic drugs. No difference was observed for gender, age or alcohol use. observed for gender, age or alcohol use.
Depressive symptoms at baseline Depressive symptoms at baseline and the risk of cognitive decline and the risk of cognitive decline
Participants with high levels of depressive Participants with high levels of depressive symptoms showed a greater decrease in symptoms showed a greater decrease in MMSE score between the baseline and 4-MMSE score between the baseline and 4-year follow-up assessments (Table 2 ). High year follow-up assessments (Table 2) . High levels of depressive symptoms were also levels of depressive symptoms were also associated with a higher risk of a 3-point associated with a higher risk of a 3-point decrease in MMSE score and with a decrease in MMSE score and with a higher risk of low cognitive functioning at higher risk of low cognitive functioning at follow-up. follow-up.
4 0 7 4 0 7 Persistent depressive symptoms Persistent depressive symptoms and cognitive decline and cognitive decline Persistent -but not episodic -depressive Persistent -but not episodic -depressive symptoms were associated with greater symptoms were associated with greater cognitive decline and with low cognitive cognitive decline and with low cognitive functioning at follow-up (Table 3 ). In order functioning at follow-up (Table 3) . In order to test whether persistent but not episodic to test whether persistent but not episodic depressive symptoms predicted cognitive depressive symptoms predicted cognitive decline in those with depressive symptoms decline in those with depressive symptoms at baseline, we compared participants at baseline, we compared participants depressed at baseline but not at 2-year depressed at baseline but not at 2-year and 4-year follow-up ('episodic', and 4-year follow-up ('episodic', n n¼39) 39) and participants depressed at baseline and and participants depressed at baseline and at 2-year and/or 4-year follow-up ('persisat 2-year and/or 4-year follow-up ('persistent', tent', n n¼77) with participants not de-77) with participants not depressed at baseline. The 'persistent' group pressed at baseline. The 'persistent' group had twice the risk of cognitive decline had twice the risk of cognitive decline (odds ratio 2.0, 95% CI 1.1-3.5) of parti-(odds ratio 2.0, 95% CI 1.1-3.5) of participants who were not depressed; episodic cipants who were not depressed; episodic depressive symptoms were not associated depressive symptoms were not associated with cognitive decline (OR 0.8, 95% CI with cognitive decline (OR 0.8, 95% CI 0.3-2.2). 0.3-2.2).
The finding that depressive symptoms The finding that depressive symptoms predict cognitive decline might be due to predict cognitive decline might be due to depressive symptoms being the consedepressive symptoms being the consequence of a slight initial cognitive decline. quence of a slight initial cognitive decline. In order to test this possibility, we considIn order to test this possibility, we considered the group of participants without ered the group of participants without cognitive decline between baseline and cognitive decline between baseline and 2-year follow-up (Table 4) . A high level of 2-year follow-up (Table 4) . A high level of depressive symptoms at 2-year follow-up depressive symptoms at 2-year follow-up was associated with a greater decrease in was associated with a greater decrease in MMSE score between the 2-year and 4-year MMSE score between the 2-year and 4-year follow-up assessments in this group. follow-up assessments in this group.
Depressive affect Depressive affect
Linear and logistic regression models Linear and logistic regression models adjusted for baseline cognitive scores and adjusted for baseline cognitive scores and covariables were used to examine the covariables were used to examine the association between the sub-score association between the sub-score 'depressive affect' and cognitive decline. 'depressive affect' and cognitive decline. In a linear regression model, depressive In a linear regression model, depressive affect was associated with a greater affect was associated with a greater decrease in MMSE score between baseline decrease in MMSE score between baseline and 4-year follow-up ( and 4-year follow-up (b b¼7 70.06, 0.06, s.e. s.e.¼0.02, 0.02, P P¼0.0003). Logistic regressions 0.0003). Logistic regressions showed that depressive affect was also assoshowed that depressive affect was also associated with a higher risk of low cognitive ciated with a higher risk of low cognitive 4 0 8 4 0 8 functioning at follow-up (OR 1.07, 95% CI functioning at follow-up (OR 1.07, 95% CI 1.01-1.13) and a higher risk of a 3-point 1.01-1.13) and a higher risk of a 3-point decrease in MMSE score (OR 1.06, 95% decrease in MMSE score (OR 1.06, 95% CI 1.00-1.12). CI 1.00-1.12).
DISCUSSION DISCUSSION
In this study initially high levels of depresIn this study initially high levels of depressive symptoms predicted cognitive decline sive symptoms predicted cognitive decline in an elderly population of 1003 persons in an elderly population of 1003 persons with good cognitive functioning at recruitwith good cognitive functioning at recruitment. People with initially high depressive ment. People with initially high depressive symptom levels were more at risk of having symptom levels were more at risk of having persistent low cognitive functioning at persistent low cognitive functioning at follow-up. These associations concerned follow-up. These associations concerned those with persistent but not episodic dethose with persistent but not episodic depressive symptoms. These results are in pressive symptoms. These results are in agreement with longitudinal studies showagreement with longitudinal studies showing that depressive symptoms are predictive ing that depressive symptoms are predictive of cognitive decline (Bassuk of cognitive decline (Bassuk et al et al, 1998; , 1998; Chen Chen et al et al, 1999; Yaffe , 1999; Yaffe et al et al, 1999; , 1999; Geerlings Geerlings et al et al, 2000) . , 2000).
Mechanisms of association Mechanisms of association
Different mechanisms may explain why Different mechanisms may explain why depressive symptoms predict cognitive depressive symptoms predict cognitive decline. Depression may be a psychological decline. Depression may be a psychological reaction to perceived cognitive loss. reaction to perceived cognitive loss. Schmand Schmand et al et al (1997) found that depressive (1997) found that depressive symptoms at baseline did not predict future symptoms at baseline did not predict future dementia when memory complaints were dementia when memory complaints were accounted for. In our study depressive accounted for. In our study depressive symptoms preceded cognitive decline, in symptoms preceded cognitive decline, in the absence of previous loss of cognitive the absence of previous loss of cognitive performance; it is therefore unlikely that performance; it is therefore unlikely that in our group depression is only a psychoin our group depression is only a psychological reaction to perceived cognitive loss. logical reaction to perceived cognitive loss. On the other hand, it is possible that the On the other hand, it is possible that the MMSE does not permit the evaluation of MMSE does not permit the evaluation of finer cognitive losses. Cognitive deficits finer cognitive losses. Cognitive deficits usually associated with depression may be usually associated with depression may be responsible for an earlier onset of cognitive responsible for an earlier onset of cognitive decline or dementia. However, in our study decline or dementia. However, in our study depressive symptoms also predicted cognidepressive symptoms also predicted cognitive decline in participants with the highest tive decline in participants with the highest MMSE scores, so it is not likely that this MMSE scores, so it is not likely that this phenomenon can explain all the data. phenomenon can explain all the data.
Somatic symptoms such as fatigue or Somatic symptoms such as fatigue or concentration disorders may be early sympconcentration disorders may be early symptoms of dementia; they are also symptoms toms of dementia; they are also symptoms of depressive disorders and are included as of depressive disorders and are included as items of depression rating scales. A high items of depression rating scales. A high depression score may thus reflect early depression score may thus reflect early symptoms of dementia. In our study, the symptoms of dementia. In our study, the observation that the affective dimension of observation that the affective dimension of CES-D was predictive of cognitive decline CES-D was predictive of cognitive decline shows that the observed association shows that the observed association between depressive score and subsequent between depressive score and subsequent cognitive decline was not only due to the cognitive decline was not only due to the somatic component of depression. somatic component of depression.
In our study group of people with initial In our study group of people with initial depressive symptoms, persistent (but not depressive symptoms, persistent (but not episodic) depression was associated with a episodic) depression was associated with a higher risk of cognitive decline. This result higher risk of cognitive decline. This result is in agreement with the observation that is in agreement with the observation that people with depressive symptoms often people with depressive symptoms often suffer from cognitive impairment, which suffer from cognitive impairment, which may be severe (pseudo-dementia) but is may be severe (pseudo-dementia) but is generally transitory and resolves on treatgenerally transitory and resolves on treatment of the depression (Stoudemire ment of the depression (Stoudemire et al et al, , 1993) . The fact that initially high levels of 1993). The fact that initially high levels of depressive symptoms predict subsequent depressive symptoms predict subsequent persistent low cognitive functioning persistent low cognitive functioning together with the observation that pertogether with the observation that persistent but not episodic depressive episodes sistent but not episodic depressive episodes are associated with cognitive decline are associated with cognitive decline suggest that a chronic mechanism is responsuggest that a chronic mechanism is responsible for the observed association. Depressible for the observed association. Depressive symptoms may be a prodrome of sive symptoms may be a prodrome of cognitive decline -the early manifestation cognitive decline -the early manifestation of a neurodegenerative process, causing of a neurodegenerative process, causing depression and dementia. Depressive sympdepression and dementia. Depressive symptoms and cognitive decline are linked to toms and cognitive decline are linked to modifications in activity of similar cerebral modifications in activity of similar cerebral areas (Baker areas (Baker et al et al, 1997) . Some studies have , 1997). Some studies have found that both are associated with the prefound that both are associated with the presence of signal hyperintensities on magnetic sence of signal hyperintensities on magnetic resonance brain scans (O'Brien resonance brain scans (O'Brien et al et al, 1996) . , 1996). The loss of noradrenergic neurons associThe loss of noradrenergic neurons associated with dementia might also explain ated with dementia might also explain depression as a prodrome of dementia depression as a prodrome of dementia (Forstl (Fö rstl et al et al, 1992) . Alternatively, depres-, 1992). Alternatively, depression might represent a causal factor in sion might represent a causal factor in cognitive decline. Some studies indicate cognitive decline. Some studies indicate that early-onset depression (Palsson that early-onset depression (Palsson et al et al, , 1999) or depression that has a history of 1999) or depression that has a history of 10 years or more (Speck 10 years or more (Speck et al et al, 1995 (Speck et al et al, ) are , 1995 are stronger risk factors for dementia. Some stronger risk factors for dementia. Some authors have proposed that chronic depresauthors have proposed that chronic depression causes cognitive decline by the release sion causes cognitive decline by the release of adrenocorticotrophic hormone and the of adrenocorticotrophic hormone and the consequent secretion of glucocorticoids consequent secretion of glucocorticoids (O'Brien, 1997) . Prolonged secretion of (O'Brien, 1997) . Prolonged secretion of glucocorticoids may have harmful effects glucocorticoids may have harmful effects and lead to hippocampal atrophy and lead to hippocampal atrophy (Sapolsky, 1996) . (Sapolsky, 1996) .
Practical and clinical implications Practical and clinical implications
Although it is not possible to define causal Although it is not possible to define causal mechanisms in an epidemiological study, mechanisms in an epidemiological study, the fact that depression predicts cognitive the fact that depression predicts cognitive decline in elderly people has practical and decline in elderly people has practical and clinical implications. The detection of clinical implications. The detection of depressive symptoms in these people is depressive symptoms in these people is important because early treatment of important because early treatment of depression may improve prognosis. In addidepression may improve prognosis. In addition, depressive symptoms, especially when tion, depressive symptoms, especially when they are persistent, may be the first sign of they are persistent, may be the first sign of the decrease in cognitive functioning, carrythe decrease in cognitive functioning, carrying not only a higher risk of dementia, but ing not only a higher risk of dementia, but also a higher mortality (Gussekloo also a higher mortality (Gussekloo et al et al, , 1997; Rozzini 1997; Rozzini et al et al, 1998) . People with , 1998) . People with cognitive decline may benefit from drugs cognitive decline may benefit from drugs that might slow the progression of the disthat might slow the progression of the disease. Nevertheless, diagnosis of depression ease. Nevertheless, diagnosis of depression is more difficult in elderly people, in whom is more difficult in elderly people, in whom symptoms such as fatigue, loss of libido and symptoms such as fatigue, loss of libido and sleep disturbances occur more frequently sleep disturbances occur more frequently even in the absence of depression. A posseven in the absence of depression. A possible consequence is that chronic depression ible consequence is that chronic depression in this age group may be underdiagnosed, in this age group may be underdiagnosed, because somatic symptoms are attributed because somatic symptoms are attributed to physical rather than psychiatric causes to physical rather than psychiatric causes (Hasin & Link, 1988) . In our study only (Hasin & Link, 1988) . In our study only 4% of the group with high levels of depres-4% of the group with high levels of depressive symptoms were receiving specific (antisive symptoms were receiving specific (antidepressant) treatment. A high proportion of depressant) treatment. A high proportion of people with chronic depression use benzopeople with chronic depression use benzodiazepines (Bonner & Howard, 1995) , diazepines (Bonner & Howard, 1995) , which have been associated in the elderly which have been associated in the elderly with a higher risk of cognitive impairment with a higher risk of cognitive impairment (Gorenstein (Gorenstein et al et al, 1995) . , 1995).
Limitations of the study Limitations of the study
In our study no history of depressive sympIn our study no history of depressive symptoms was obtained and no diagnosis of toms was obtained and no diagnosis of depressive disorder was made. It cannot depressive disorder was made. It cannot therefore be deduced whether early or late therefore be deduced whether early or late depression is responsible for cognitive depression is responsible for cognitive decline and which clinical form of depresdecline and which clinical form of depression is associated with cognitive impairsion is associated with cognitive impairment. Moreover, study participants who ment. Moreover, study participants who were not followed up had higher levels of were not followed up had higher levels of depressive symptoms and lower MMSE depressive symptoms and lower MMSE scores at baseline than those who were scores at baseline than those who were followed up. The association between followed up. The association between depressive symptoms and cognitive decline depressive symptoms and cognitive decline may be underestimated. However, few may be underestimated. However, few patients were lost to follow-up (13%) and patients were lost to follow-up (13%) and so major bias is unlikely. so major bias is unlikely.
In conclusion, our finding that depresIn conclusion, our finding that depressive symptoms predict cognitive decline sive symptoms predict cognitive decline may have important clinical implications. may have important clinical implications. Depression may be a harbinger of initial Depression may be a harbinger of initial cognitive decline. cognitive decline. The interaction between mood and cognitive function interaction between mood and cognitive function studied with PET. studied with PET. Psychological Medicine Psychological Medicine, , 27 27, 565^578. , 565^578. Without a history of depressive symptoms or a diagnosis of depressive disorder for the patients in this study it is not possible to establish whether early or late the patients in this study it is not possible to establish whether early or late depression is responsible for cognitive decline or which clinical form of depression is depression is responsible for cognitive decline or which clinical form of depression is associated with cognitive decline. associated with cognitive decline.
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& & Participants who were not followed up (13%) had higher levels of depressive Participants who were not followed up (13%) had higher levels of depressive symptoms and lower Mini-Mental State Examination (MMSE) scores at baseline than symptoms and lower Mini-Mental State Examination (MMSE) scores at baseline than those who were followed up; the association between depressive symptoms and those who were followed up; the association between depressive symptoms and cognitive decline may therefore be underestimated. cognitive decline may therefore be underestimated.
& & Although our data suggest that depressive symptoms predict cognitive decline in Although our data suggest that depressive symptoms predict cognitive decline in study participants with previously stable good performances, it is possible that the study participants with previously stable good performances, it is possible that the MMSE was inadequate to detect more subtle cognitive decline. MMSE was inadequate to detect more subtle cognitive decline.
